ArticleNutrients2025
Non-HDL Cholesterol in Dyslipidemia Screening Among Korean Adolescents: A National Population-Based Survey.
Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesIn pediatric lipid screening, non-high-density lipoprotein (non-HDL) cholesterol has gained relevance as a clinically feasible indicator that is increasingly applied. We assessed the population-level diagnostic performance and the influence of familial lipid risk in Korean adolescents.
methodsA nationally representative sample of 6989 adolescents aged 10-19 years (3684 boys and 3305 girls) was examined from the Korean National Health and Nutrition Examination Survey. We analyzed this nationally representative data to evaluate weighted and adjusted associations among non-HDL cholesterol level at or above 145 mg/dL, dyslipidemia, and parental lipid status.
resultsThe overall prevalence of dyslipidemia was 28.2% and 26.3% in Korean adolescent boys and girls, respectively. The prevalence of non-HDL cholesterol at or above 145 mg/dL was 7.2% and 9.2% in adolescent boys and girls, respectively. Elevated non-HDL cholesterol levels detected high directly measured or calculated low-density lipoprotein (LDL) cholesterol levels with a sensitivity of 72.9% and 54.0%, and a specificity of 99.7% and 99.8%, respectively, in adolescent boys, and a sensitivity of 77.5% and 64.8%, and a specificity of 99.5% and 99.2%, respectively, in adolescent girls. Compared with total cholesterol, non-HDL cholesterol more accurately identified adolescents with elevated LDL cholesterol in both sexes. These associations remained stable regardless of familial dyslipidemia history in adjusted weighted logistic regression models.
conclusionsNon-HDL cholesterol consistently distinguished adolescents with dyslipidemia independent of familial lipid status. Although a positive parental history increased the risk, non-HDL cholesterol remained a feasible pediatric screening tool in population-based evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.